Oral plasmid DNA delivery systems for genetic immunisation

Area of Science:

• * Immunology
• * Nanotechnology
• * Molecular Biology

Background:

• * Oral administration of plasmid DNA for genetic immunization faces challenges in delivery and immune response induction.
• * Existing delivery systems often struggle with stability and efficacy when administered orally.
• * Development of robust delivery platforms is essential for advancing DNA vaccine technology.

Purpose of the Study:

• * To develop and evaluate a novel multicomponent polymer-modified liposomal delivery system for oral plasmid DNA.
• * To assess the system's ability to elicit transgene-specific immune responses upon oral administration.
• * To evaluate the potential of this system for genetic immunization applications.

Main Methods:

• * Formulation of a multicomponent polymer-modified liposomal delivery system encapsulating plasmid DNA.
• * In vitro assessment of the formulated DNA's immunogenicity using splenocyte restimulation assays.
• * Measurement of transgene-specific cytokine production as a marker of immune response.
• * Comparative analysis with existing literature on DNA delivery systems.

Main Results:

• * The polymer/liposome formulated DNA demonstrated significantly enhanced transgene-specific cytokine production in vitro.
• * The delivery system showed potential for effective oral administration of plasmid DNA.
• * The results indicate improved immune cell activation compared to conventional methods.

Conclusions:

• * The developed polymer-modified liposomal system is a promising platform for oral plasmid DNA delivery.
• * This approach holds potential for enhancing immune responses in genetic immunization strategies.
• * Further research is warranted to explore its in vivo efficacy and therapeutic applications.